Chlamydia trachomatis infections, which most frequently are asymptomatic, are major public
health concerns globally. The 2015 European C. trachomatis guideline provides: up-to-date …

In the United States, sexually transmitted diseases due to Chlamydia trachomatis and
Neisseria gonorrhoeae continue to be a major public health burden. Screening of …

These guidelines for the treatment of persons who have or are at risk for sexually transmitted
infections (STIs) were updated by CDC after consultation with professionals knowledgeable …

Background The increases in STI rates since the late 1990s in Canada have occurred
despite widespread primary care and targeted public health programs and in the setting of …

This guideline offers recommendations on the diagnostic tests, treatment regimens and
health promotion principles needed for the effective management of Chlamydia trachomatis …

Extragenital gonorrhea and chlamydia were common among men who have sex with men
attending sexually transmitted disease clinics. Most extragenital gonorrhea and chlamydia …

Background: Identification of sexually transmitted infections (STI) is limited by the infrequent
assessment of rectal STI. This study assesses usability of self-collected rectal swabs (SRS) …

Background Sexual history does not accurately identify those with extragenital Neisseria
gonorrhoeae (NG) and Chlamydia trachomatis (CT), so universal extragenital sampling is …

Mycoplasma genitalium (M. genitalium) was first isolated from the urethral swabs of two
symptomatic men with urethritis in 1980. Published prevalence rates vary greatly between …

Nucleic acid amplification testing (NAAT) has become the preferred method to detect
Chlamydia trachomatis and Neisseria gonorrhoeae, but no commercial tests are cleared by …